Aorui Bio
Aorui Bio develops blood-based whole-genome liquid biopsy tests to enable earlier cancer detection using machine learning analysis. The company sequences circulating tumor DNA and applies ML models to identify cancer-associated genomic signatures and produce risk scores. It combines genomics, computational biology, and wireless medical device delivery for point-of-care or remote screening workflows. Customers include clinical laboratories, diagnostic providers, and population screening programs seeking noninvasive early cancer screening solutions.
Aorui Bio
Aorui Bio develops blood-based whole-genome liquid biopsy tests to enable earlier cancer detection using machine learning analysis. The company sequences circulating tumor DNA and applies ML models to identify cancer-associated genomic signatures and produce risk scores. It combines genomics, computational biology, and wireless medical device delivery for point-of-care or remote screening workflows. Customers include clinical laboratories, diagnostic providers, and population screening programs seeking noninvasive early cancer screening solutions.